Atrial natriuretic peptide in spontaneous tachycardias.

Because anecdotal reports suggest that concentrations of atrial natriuretic peptide are raised during tachycardias, plasma immunoreactive atrial natriuretic peptide concentrations were measured in 34 consecutive patients when tachycardia was diagnosed and again five and 15 minutes after conversion to sinus rhythm. Plasma atrial natriuretic peptide concentrations were raised in all but four patients, and were higher in patients with known heart disease than in those without. The concentrations were higher with ventricular tachycardia than with atrial fibrillation or supraventricular tachycardia, and in acute versus chronic tachycardia. There was only a weak positive relation between ventricular rate and atrial natriuretic peptide (r = 0.31); but there was a closer inverse correlation between atrial natriuretic peptide and systolic arterial pressure (r = -0.60). Conversion to sinus rhythm was associated with a definite fall in plasma atrial natriuretic peptide concentrations. Despite very high baseline concentrations of atrial natriuretic peptide only two patients reported polyuria. It is likely that atrial pressure rather than ventricular rate determines atrial natriuretic peptide release during tachycardia. Despite the absence of polyuria in all but two patients in this study atrial peptides could still contribute to, or cause, the polyuria of tachycardias.

[1]  R. Cuneo,et al.  Renal, hemodynamic, and hormonal responses to atrial natriuretic peptide infusions in normal man, and effect of sodium intake. , 1986, The Journal of clinical endocrinology and metabolism.

[2]  S. Ball,et al.  Plasma alpha natriuretic peptide in cardiac impairment. , 1986, British medical journal.

[3]  K. Theisen,et al.  Plasma atrial natriuretic peptide concentrations during intracardiac pacing , 1986 .

[4]  E. Espiner,et al.  Radioimmunoassay and characterization of atrial natriuretic peptide in human plasma. , 1986, The Journal of clinical endocrinology and metabolism.

[5]  S. Bloom,et al.  The plasma atrial natriuretic peptide response to treatment of acute cardiac failure, spontaneous supraventricular tachycardia and induced re-entrant tachycardia in man. , 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[6]  E. Espiner,et al.  Atrial Natriuretic Peptide in Humans: Production and Clearance by Various Tissues , 1986, Hypertension.

[7]  J. Biollaz,et al.  Clinical pharmacology of atrial natriuretic (3-28) eicosahexapeptide. , 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[8]  E. H. Blaine,et al.  The character of the atrial natriuretic response: pressure and volume effects. , 1986, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[9]  R. Cuneo,et al.  Metabolic clearance rate and plasma half life of alpha-human atrial natriuretic peptide in man. , 1986, Life sciences.

[10]  J. Laragh,et al.  Relationship between renal hemodynamic and natriuretic effects of atrial natriuretic factor. , 1986, The American journal of physiology.

[11]  A. Richards,et al.  Effects of alpha-human atrial natriuretic peptide in essential hypertension. , 1985, Hypertension.

[12]  I. Tikkanen,et al.  PLASMA ATRIAL NATRIURETIC PEPTIDE IN CARDIAC DISEASE AND DURING INFUSION IN HEALTHY VOLUNTEERS , 1985, The Lancet.

[13]  I. Tikkanen,et al.  ATRIAL NATRIURETIC PEPTIDE IN PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA , 1985, The Lancet.

[14]  J. R. Ledsome,et al.  Release of atrial natriuretic peptide by atrial distension. , 1985, Canadian journal of physiology and pharmacology.

[15]  K. Imataka,et al.  POSSIBLE ROLE FOR ATRIAL NATRIURETIC PEPTIDE IN POLYURIA ASSOCIATED WITH PAROXYSMAL ATRIAL ARRHYTHMIAS , 1985, The Lancet.

[16]  E. Schiffrin,et al.  Plasma concentration of atrial natriuretic factor in a patient with paroxysmal atrial tachycardia. , 1985, The New England journal of medicine.

[17]  M. Webster,et al.  RENAL, HAEMODYNAMIC, AND HORMONAL EFFECTS OF HUMAN ALPHA ATRIAL NATRIURETIC PEPTIDE IN HEALTHY VOLUNTEERS , 1985, The Lancet.

[18]  J. Dietz Release of natriuretic factor from rat heart-lung preparation by atrial distension. , 1984, The American journal of physiology.

[19]  N. Trippodo,et al.  Natriuretic response to atrial natriuretic factor enhanced by angiotensin II and vasopressin. , 1984, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[20]  R. Danner,et al.  Hypotension with ventricular pacing: an atria vasodepressor reflex in human beings. , 1984, Journal of the American College of Cardiology.

[21]  K. Kangawa,et al.  Purification and complete amino acid sequence of α-human atrial natriuretic polypeptide (α-hANP) , 1984 .

[22]  R. Tarazi,et al.  Three cases of hypotension and syncope with ventricular pacing: possible role of atrial reflexes. , 1978, The American journal of cardiology.

[23]  S. Lochaya,et al.  Paroxysmal tachycardia with polyuria. , 1966, Annals of internal medicine.

[24]  P. Samet,et al.  Hemodynamic effects of tachycardias produced by atrial and ventricular pacing. , 1965, The American journal of medicine.

[25]  P. Wood POLYURIA IN PAROXYSMAL TACHYCARDIA AND PAROXYSMAL ATRIAL FLUTTER AND FIBRILLATION , 1963, British heart journal.

[26]  M. Schlepper,et al.  Haemodynamic effects of supraventricular tachycardias and their alterations by electrically and verapamil induced termination. , 1978, Cardiovascular research.

[27]  B. Kisch Electron microscopy of the atrium of the heart. I. Guinea pig. , 1956, Experimental medicine and surgery.